Download Therapeutic Apheresis Order

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Vectors in gene therapy wikipedia , lookup

Medical ethics wikipedia , lookup

Patient safety wikipedia , lookup

Electronic prescribing wikipedia , lookup

Bio-MEMS wikipedia , lookup

Organ-on-a-chip wikipedia , lookup

Transcript
Date
Name
MRN, DOB
Location
Mount Sinai Hospital
New York, NY 10029
APHERESIS UNIT (212) 241-6104
Physician/Service
THERAPEUTIC APHERESIS ORDER SET
Patient Diagnosis: _________________________ Patient Age: _______ Referring MD____________________
Vital sign frequency:
Routine
q1°
Location of procedure:
Apheresis Unit
Other: ______________
Apheresis instrument:
Spectra
Other_______________
Apheresis Schedule/Frequency:
Continuous
_____________________________________
Plasmapheresis: Plasma volumes to exchange ___________
Replacement fluid:
Red cell exchange:
Cytoreduction:
Replacement fluid:
Anticoagulant:
Patient:
5% Albumin___________%
0.9% NaCl ___________ %
FFP____________ %
Cryo-poor plasma ________%
PRBC volumes to exchange ___________
Average Hct of red cell units_______
End point patient Hct__________%
Desired FCR___________%
WBC
Target cell count:
Fluid balance desired: ___________
Platelets
_________________
Blood volumes for processing: ______________
5% Albumin______%
ACD-A
0.9% NaCl ___________ %
FFP____________ %
Heparin: ________U/500 mL ACD-A and AC: WB ratio ___________
Weight ____________ lb / kg
Safe ECV _________________ mL
Height ___________ in / cm
Red cell prime:
TBV ______________mL
Undiluted
Diluted
Hb/Hct ________ Plts_________ WBC_________ PT/aPTT ___________Serum Ca _______ LFTs _______
Labs to order:
Pre______________________________________
□ADMTS-13 (vWFPA) □T & S
Post______________________________________
Medications:
______ mL 10% Calcium gluconate (94 mg/mL) in 150mL NS for continuous drip throughout procedure
Benadryl IV/po ________mg
Tylenol po ___________mg
Heparin dwell ________units per lumen.
Solu-Cortef/Medrol IV_______mg
Sterile dressing change, as needed.
Special instruction/comments: ________________________________________________________________________
____________________________________________________________________________________________
____________________________________________________________________________________________
Attending Signature _______________________________
Date/Time ____________________
Nurse’s Signature _________________________________
Date/Time____________________
APH 507v2
Page 1 of 2
Physician’s Additional Instructions
Date/Time____________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
_________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________
APH 507v2
Page 2 of 2